Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.
about
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.Increased Cumulative Incidence of Dermatomyositis in Ulcerative Colitis: a Nationwide Cohort StudyA Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.The Clinical Features of Myositis-Associated Autoantibodies: a Review.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Integrated classification of inflammatory myopathies.The pathogenesis of dermatomyositis.Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.What autoantibody tests should become widely available to help scleroderma diagnosis and management?Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.Bench to bedside review of myositis autoantibodies.Potential Chronotherapeutic Optimization of Antimalarials in Systemic Lupus Erythematosus: Is Toll-Like Receptor 9 Expression Dependent on the Circadian Cycle in Humans?
P2860
Q35153899-B39241AF-21DA-4FF1-860B-F851A28E3344Q35532333-8AF72DBC-0BCF-45E7-B249-46EBE58595ADQ37023992-9CF8F032-02F5-4C9C-88B8-6D78F75CB00FQ38596370-EA9A7031-2B69-4EFE-A30B-EFB9B1BED3DCQ38603422-6A1A3C47-0CBA-4861-A88F-4822E79D7E6EQ38646384-F47171B5-6CF7-4C5D-A067-1995FD3384C0Q39027323-EB40D832-CBA0-4464-B61A-57B621C7E2A5Q39329125-888B9386-D51A-44E0-A7C0-D162DB19BF06Q40747808-6E44E0C5-3A1F-40B4-B195-C2F7C335FD17Q42370114-80E21505-834F-4F93-8CB1-C06C9333C77DQ52597638-7F4DDC44-5B7E-4771-B57A-5A4CB28808F5Q54248023-2A0D4B93-6734-4197-85F9-993D676E3C88Q55425108-61CC3DDA-8002-470B-91CD-135447DA39F8Q58051940-AEEC188A-C131-451B-A62D-5CAEF0683D1F
P2860
Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Implications in the difference ...... m Mexico City and Guadalajara.
@ast
Implications in the difference ...... m Mexico City and Guadalajara.
@en
type
label
Implications in the difference ...... m Mexico City and Guadalajara.
@ast
Implications in the difference ...... m Mexico City and Guadalajara.
@en
prefLabel
Implications in the difference ...... m Mexico City and Guadalajara.
@ast
Implications in the difference ...... m Mexico City and Guadalajara.
@en
P2093
P2860
P356
P1476
Implications in the difference ...... om Mexico City and Guadalajara
@en
P2093
Beatriz T Martin-Marquez
Claudia Cruz-Gonzalez
Edward K L Chan
Hermes U Ramírez-Sánchez
Jason Y F Chan
Jorge I Gamez-Nava
Laura Gonzalez-Lopez
Lilia Andrade-Ortega
Luis J Jara
Mario Salazar-Páramo
P2860
P2888
P356
10.1186/AR4207
P577
2013-04-04T00:00:00Z
P5875
P6179
1035605129